Abu Dhabi, UAE – The Emirates Genome Council on Tuesday launched the National Genome Strategy, which is expected to provide a comprehensive framework of legislation and governance to support the development and implementation of genomic programs over the next decade.
The National Genome Strategy will support efficiency in the country’s healthcare sector through preventive medicine programs that will focus on genetic risk, and precision medicine programs that target genetic and rare diseases, WAM reported.
It will also support doctors in taking proactive steps to reduce the prevalence of certain diseases, enable early intervention, and help to identify the most effective treatments. As a result, genomic sciences will reduce health sector costs and drug expenditures over the long term.
Genome programs will also help create new economic opportunities in the UAE by attracting partnerships in fields such as artificial intelligence, advanced medical care, pharmaceuticals, and research and technology. It will also nurture specialized local talent, as well as create jobs and other opportunities in future-focused industries.
UAE President Sheikh Mohamed bin Zayed said, “Science and knowledge have always been key drivers of the UAE’s development. Our priority is to ensure the best healthcare and quality of life for our people.”
UAE Prime Minister Sheikh Mohammed bin Rashid Al Maktoum said the strategy highlights the country’s position as a hub for advanced healthcare research, innovation and future technology use.
Chairman of the Emirates Genome Council Sheikh Khaled said the strategy ensures a sustainable ecosystem to enhance the development of priority preventive and personalized healthcare solutions for UAE’s citizens.
“The Council will also oversee the ‘One Million Genome’ project which will enable the healthcare sector and enhance its services,” he added.
Sara bint Yousef Al Amiri, Secretary-General of the Emirates Genome Council said key pillars of the strategy includes “establishing an agile framework of legislation and governance; creating a harmonized and secure data infrastructure; developing top-tier genomic research and innovation capabilities.”
This also includes “focusing on genomic applications that align with public health priorities; and building strategic partnerships that accelerate delivery of best-in-class programs.”
She highlighted the Emirati Genome Program (EGP) as a foundational project within the National Genome Strategy.
She added, “Understanding the genetic makeup of our citizens will help medical teams deliver personalized healthcare services to each one. Moreover, this wealth of information will help us develop solutions to limit the spread of genetic and chronic diseases, such as diabetes, blood pressure conditions, and cancer.”
“Our database today contains whole genome sequencing data from around 400,000 citizens. Our target is to collect one million samples nationwide and we look forward to the participation of all Emiratis,” she added.
Al Amiri also highlighted the UAE Reference Genome program, which will analyze more than 50,000 Emirati genome samples using new generation sequencing technology.